Abstract
An alternative heterogeneously palladium catalysed procedure for the synthesis of functional stilbenes and bibenzyls is reported. Starting from aryl bromides and using simple commercially available Pd/C catalyst at a low catalytic rate (1 mol%), stilbenes are obtained with 30-100% GC-yields and bibenzyls are produced in a one-pot fashion with 27-100% GC-yields. The procedure showed, however, some limitations when applied to strongly deactivated aryl bromides that could be in some extent overcome by using corresponding iodo derivatives.
Keywords: Stilbene synthesis, bibenzyl synthesis, one-pot synthesis, heterogeneous palladium catalyst
Letters in Organic Chemistry
Title: Efficient Heterogeneously Palladium-Catalysed Synthesis of Stilbenes and Bibenzyls
Volume: 6 Issue: 1
Author(s): Giuseppe Cusati, Anja Wedig and Laurent Djakovitch
Affiliation:
Keywords: Stilbene synthesis, bibenzyl synthesis, one-pot synthesis, heterogeneous palladium catalyst
Abstract: An alternative heterogeneously palladium catalysed procedure for the synthesis of functional stilbenes and bibenzyls is reported. Starting from aryl bromides and using simple commercially available Pd/C catalyst at a low catalytic rate (1 mol%), stilbenes are obtained with 30-100% GC-yields and bibenzyls are produced in a one-pot fashion with 27-100% GC-yields. The procedure showed, however, some limitations when applied to strongly deactivated aryl bromides that could be in some extent overcome by using corresponding iodo derivatives.
Export Options
About this article
Cite this article as:
Cusati Giuseppe, Wedig Anja and Djakovitch Laurent, Efficient Heterogeneously Palladium-Catalysed Synthesis of Stilbenes and Bibenzyls, Letters in Organic Chemistry 2009; 6 (1) . https://dx.doi.org/10.2174/157017809787003043
DOI https://dx.doi.org/10.2174/157017809787003043 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin
Anti-Cancer Agents in Medicinal Chemistry Acknowledgements to Reviewers
Recent Patents on Anti-Cancer Drug Discovery Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery Clinical Implications of Patient-Provider Agreements in Opioid Prescribing
Current Drug Safety Computational Methods and Algorithms for Mass-Spectrometry Based Differential Proteomics
Current Proteomics Colon as Target for Drug Delivery
Current Drug Therapy Camptothecins and Key Lessons in Drug Design
Drug Design Reviews - Online (Discontinued) Editorial [Hot Topic:Targeted Therapeutics – From Chemical Structures to Diagnostic and Therapeutic Agents(Executive Editor: Christine Armbruster)]
Current Pharmaceutical Design Spirulina paltensis: Food and Function
Current Nutrition & Food Science Current Overview of Lung Cancer from Pathology, Screening to Treatment
Current Cancer Therapy Reviews Editorial [Hot topic: Molecular Mechanisms of Cancer Cell Death (Executive Editor: Ricardo Perez-Tomas)]
Current Pharmaceutical Design Synthesis and Evaluation of Novel Erucin Analogues as Potential Antitumor Compounds
Letters in Organic Chemistry Antitumor Carbazoles
Anti-Cancer Agents in Medicinal Chemistry Homology Modeling and Docking Studies of Bcl-2 and Bcl-xL with Small Molecule Inhibitors: Identification and Functional Studies
Current Topics in Medicinal Chemistry Modified Nucleosides That Can Be Incorporated into DNA Enzymatically or in Live Cells
Current Organic Chemistry Estrogen Receptor Neurobiology and its Potential for Translation into Broad Spectrum Therapeutics for CNS Disorders
Current Molecular Pharmacology Characterization of a New Allelic Variant of Triosephosphate Isomerase from the LNCaP Human Prostate Cancer Cell Line: Enzyme Inhibition and Spectroscopic Studies
Current Enzyme Inhibition The Use of Microarrays to Study Childhood Developmental Brain Disorders
Current Genomics Meet Our Editorial Board Member
Current Biomarkers (Discontinued) Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials
Reviews on Recent Clinical Trials